Showing results (21-30 of 162) with videos related to

Sort By:
Pageof 17
Clinical Journal of Gastroenterology|November 12, 2025
Tocilizumab for steroid-refractory hemophagocytic syndrome after durvalumab and tremelimumab for advanced hepatocellular carcinomaYuki Kanayama, Takeshi Hatanaka, Yoshiki Tanaka, et al.
Clinical Journal of Gastroenterology|February 23, 2023
Three cases of immune-related hypopituitarism after atezolizumab-bevacizumab treatment for hepatocellular carcinomaNozomi Furuichi, Atsushi Naganuma, Takuya Kaburagi, et al.
Clinical Journal of Gastroenterology|May 18, 2022
A case of conversion hepatectomy for huge hepatocellular carcinoma with adrenal metastasis and vascular invasion after atezolizumab-bevacizumab treatmentTakashi Hoshino, Atsushi Naganuma, Ai Furusawa, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|May 22, 2026
Compensatory Hepatic Hypertrophy After Carbon Ion Radiotherapy for Hepatocellular Carcinoma: Factors Associated With Its Development and Relationship With PrognosisTatsuma Murakami, Takeshi Hatanaka, Yumeo Tateyama, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|May 14, 2017
Factors predicting overall response and overall survival in hepatocellular carcinoma patients undergoing balloon-occluded transcatheter arterial chemoembolization: A retrospective cohort studyTakeshi Hatanaka, Hirotaka Arai, Mitsuhiko Shibasaki, et al.
Internal Medicine (Tokyo, Japan)|April 10, 2024
Drug-induced Steatohepatitis Caused by Long-term Use of Topical Steroids for Atopic DermatitisYuki Tamura, Atsushi Naganuma, Yuhei Suzuki, et al.
Internal Medicine (Tokyo, Japan)|June 28, 2019
Ledipasvir and Sofosbuvir for Acute Hepatitis C Virus Monoinfection Associated with a High Risk of Acute Liver FailureTakeshi Hatanaka, Atsushi Naganuma, Yumeo Tateyama, et al.
Pageof 17